Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,940,628
+$2,131,697 QoQ
Shares Held
60,275
+47.2% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 27.284944006636252.ToString("F0")%
Shared 0.ToString("F0")%
None 72.71505599336375.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,515,258 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
20,166 | $11,958,034 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
60,275 | $7,940,628 | |
| 3 | ZTS |
Zoetis Inc.
|
55,270 | $6,533,466 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
172,961 | $3,203,237 | |
| 5 | HLN |
Haleon plc
|
293,965 | $2,942,589 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,408 | $2,120,688 | |
| 7 | VTRS |
Viatris Inc
|
146,854 | $1,983,997 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
78,205 | $1,871,445 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,940,628 | 60,275 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,808,931 | 40,957 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $4,436,288 | 31,602 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,754,758 | 13,961 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,325,209 | 11,982 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,653,288 | 12,112 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $918,188 | 7,969 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,118,293 | 8,123 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,061,018 | 7,693 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $697,273 | 5,292 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $458,212 | 4,073 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $318,262 | 3,375 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $329,369 | 3,254 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $368,591 | 3,086 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $300,255 | 2,827 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $328,215 | 3,367 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $275,343 | 2,937 | Shares | Sole | 2022-05-10 | |
| 2021-03-31 | $287,860 | 2,960 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $229,273 | 2,392 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $224,724 | 1,842 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||